[Form 4] Myriad Genetics Inc Insider Trading Activity
Myriad Genetics insider grant and resulting ownership: Benjamin R. Wheeler, identified as the company's Chief Financial Officer, received a grant of 60,000 time-based restricted stock units (RSUs) on 08/16/2025. The RSUs were granted at a reported price of $0 and represent contingent rights to one share of common stock each. Following the grant, the reporting person beneficially owned 95,210 shares. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date. The Form 4 filing is dated 08/19/2025 and bears the signature entry by Justin Hunter on behalf of Benjamin R. Wheeler.
Assegnazione interna e conseguente partecipazione in Myriad Genetics: Benjamin R. Wheeler, indicato come Chief Financial Officer della societ脿, ha ricevuto un鈥檃ssegnazione di 60.000 unit脿 di azioni vincolate basate sul tempo (RSU) il 16/08/2025. Le RSU sono state concesse a un prezzo riportato di $0 e rappresentano diritti condizionati a una azione ordinaria ciascuno. Dopo l鈥檃ssegnazione, la persona segnalante deteneva beneficiariamente 95.210 azioni. Le RSU maturano in tre rate annuali uguali a partire dal primo anniversario della data di assegnazione. Il modulo Form 4 猫 datato 19/08/2025 e riporta la firma di Justin Hunter per conto di Benjamin R. Wheeler.
Concesi贸n interna y participaci贸n resultante en Myriad Genetics: Benjamin R. Wheeler, identificado como el Director Financiero de la compa帽铆a, recibi贸 una concesi贸n de 60.000 unidades de acciones restringidas basadas en tiempo (RSU) el 16/08/2025. Las RSU se otorgaron a un precio informado de $0 y representan derechos contingentes a una acci贸n ordinaria cada una. Tras la concesi贸n, la persona informante pose铆a beneficiariamente 95.210 acciones. Las RSU se consolidan en tres cuotas anuales iguales a partir del primer aniversario de la fecha de concesi贸n. El formulario Form 4 est谩 fechado el 19/08/2025 y lleva la firma de Justin Hunter en nombre de Benjamin R. Wheeler.
Myriad Genetics 雮措秬 攵�鞐� 氚� 攴胳棎 霐半ジ 氤挫湢: 須岇偓鞚� 斓滉碃鞛毂呾瀯鞛�(Chief Financial Officer)搿� 旮办灛霅� Benjamin R. Wheeler電� 2025雲� 8鞗� 16鞚�鞐� 60,000臧滌潣 旮瓣皠 旮半皹 鞝滍暅 欤检嫕 雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 RSU電� 氤搓碃霅� 攵�鞐皜臧� $0搿� 旮半霅橃棃鞙茧┌ 臧� 雼渼電� 氤错喌欤� 1欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 雮橅儉雰呺媹雼�. 攵�鞐� 鞚错泟 氤搓碃鞛愲姅 順滍儩鞝� 靻岇湢搿� 95,210欤茧ゼ 氤挫湢頄堨姷雼堧嫟. RSU電� 攵�鞐澕鞚� 觳� 氩堨Ц 旮半厫鞚茧秬韯� 鞁滌瀾頃� 3雲勳棎 瓯胳硱 毵る厔 霃欖澕頃� 牍勳湪搿� 旆摑霅╇媹雼�. Form 4 鞝滌稖靹滊姅 2025雲� 8鞗� 19鞚�鞛愳澊氅� Benjamin R. Wheeler毳� 雽�鞁犿暣 Justin Hunter臧� 靹滊獏頄堨姷雼堧嫟.
Attribution interne et participation r茅sultante chez Myriad Genetics : Benjamin R. Wheeler, identifi茅 comme le directeur financier de la soci茅t茅, a re莽u une attribution de 60 000 unit茅s d'actions restreintes fond茅es sur le temps (RSU) le 16/08/2025. Les RSU ont 茅t茅 octroy茅es 脿 un prix d茅clar茅 de 0 $ et repr茅sentent des droits conditionnels 脿 une action ordinaire chacune. Apr猫s l'attribution, la personne d茅clarante d茅tenait b茅n茅ficiairement 95 210 actions. Les RSU acqui猫rent en trois versements annuels 茅gaux 脿 compter du premier anniversaire de la date d'attribution. Le formulaire Form 4 est dat茅 du 19/08/2025 et porte la signature de Justin Hunter au nom de Benjamin R. Wheeler.
Interne Gew盲hrung und daraus resultierender Anteil bei Myriad Genetics: Benjamin R. Wheeler, als Chief Financial Officer des Unternehmens genannt, erhielt am 16.08.2025 eine Zuteilung von 60.000 zeitabh盲ngigen Restricted Stock Units (RSUs). Die RSUs wurden zu einem angegebenen Preis von $0 gew盲hrt und stellen jeweils bedingte Rechte auf eine Stammaktie dar. Nach der Gew盲hrung besa脽 die meldende Person wirtschaftlich 95.210 Aktien. Die RSUs fallen in drei gleichen j盲hrlichen Raten ab dem ersten Jahrestag des Gew盲hrungsdatums an. Die Form 4 ist datiert auf 19.08.2025 und tr盲gt die Unterschrift von Justin Hunter im Namen von Benjamin R. Wheeler.
- 60,000 RSU grant ties the CFO's compensation to shareholder value through equity-based incentives
- Multi-year vesting (three equal annual installments) supports executive retention and alignment over time
- Clear disclosure of grant date, vesting schedule, and resultant beneficial ownership (95,210 shares) in Form 4
- Grant issued at $0 indicates compensation issuance rather than purchase, which will dilute shareholders when RSUs settle
- Form 4 does not disclose any performance conditions tied to the RSUs, only time-based vesting
Insights
TL;DR: CFO received 60,000 RSUs that vest over three years, increasing insider alignment but adding future share dilution.
The grant of 60,000 time-based restricted stock units to the Chief Financial Officer is a standard executive compensation action intended to retain and align management with shareholder interests. Each RSU converts to one share upon vesting and the award vests in three equal annual installments starting one year after grant, which creates a multi-year retention schedule. The reported grant price of $0 indicates these are compensation awards rather than open-market purchases. Investors should note the immediate increase in beneficial ownership to 95,210 shares and that eventual settlement of vested RSUs will increase the company鈥檚 outstanding shares.
TL;DR: Time-based RSUs with multi-year vesting reflect routine governance practice to retain senior executives.
The structure鈥攖ime-based RSUs vesting in three equal annual installments鈥攁ligns with common governance practices to encourage continued service and long-term performance focus. The Form 4 discloses the material terms necessary for shareholders to assess timing and potential dilution. The filing does not disclose any performance-based conditions or accelerated vesting triggers; it only specifies time-based vesting. This is a routine, not atypical, compensation disclosure for an officer-level recipient.
Assegnazione interna e conseguente partecipazione in Myriad Genetics: Benjamin R. Wheeler, indicato come Chief Financial Officer della societ脿, ha ricevuto un鈥檃ssegnazione di 60.000 unit脿 di azioni vincolate basate sul tempo (RSU) il 16/08/2025. Le RSU sono state concesse a un prezzo riportato di $0 e rappresentano diritti condizionati a una azione ordinaria ciascuno. Dopo l鈥檃ssegnazione, la persona segnalante deteneva beneficiariamente 95.210 azioni. Le RSU maturano in tre rate annuali uguali a partire dal primo anniversario della data di assegnazione. Il modulo Form 4 猫 datato 19/08/2025 e riporta la firma di Justin Hunter per conto di Benjamin R. Wheeler.
Concesi贸n interna y participaci贸n resultante en Myriad Genetics: Benjamin R. Wheeler, identificado como el Director Financiero de la compa帽铆a, recibi贸 una concesi贸n de 60.000 unidades de acciones restringidas basadas en tiempo (RSU) el 16/08/2025. Las RSU se otorgaron a un precio informado de $0 y representan derechos contingentes a una acci贸n ordinaria cada una. Tras la concesi贸n, la persona informante pose铆a beneficiariamente 95.210 acciones. Las RSU se consolidan en tres cuotas anuales iguales a partir del primer aniversario de la fecha de concesi贸n. El formulario Form 4 est谩 fechado el 19/08/2025 y lleva la firma de Justin Hunter en nombre de Benjamin R. Wheeler.
Myriad Genetics 雮措秬 攵�鞐� 氚� 攴胳棎 霐半ジ 氤挫湢: 須岇偓鞚� 斓滉碃鞛毂呾瀯鞛�(Chief Financial Officer)搿� 旮办灛霅� Benjamin R. Wheeler電� 2025雲� 8鞗� 16鞚�鞐� 60,000臧滌潣 旮瓣皠 旮半皹 鞝滍暅 欤检嫕 雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 頃措嫻 RSU電� 氤搓碃霅� 攵�鞐皜臧� $0搿� 旮半霅橃棃鞙茧┌ 臧� 雼渼電� 氤错喌欤� 1欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 雮橅儉雰呺媹雼�. 攵�鞐� 鞚错泟 氤搓碃鞛愲姅 順滍儩鞝� 靻岇湢搿� 95,210欤茧ゼ 氤挫湢頄堨姷雼堧嫟. RSU電� 攵�鞐澕鞚� 觳� 氩堨Ц 旮半厫鞚茧秬韯� 鞁滌瀾頃� 3雲勳棎 瓯胳硱 毵る厔 霃欖澕頃� 牍勳湪搿� 旆摑霅╇媹雼�. Form 4 鞝滌稖靹滊姅 2025雲� 8鞗� 19鞚�鞛愳澊氅� Benjamin R. Wheeler毳� 雽�鞁犿暣 Justin Hunter臧� 靹滊獏頄堨姷雼堧嫟.
Attribution interne et participation r茅sultante chez Myriad Genetics : Benjamin R. Wheeler, identifi茅 comme le directeur financier de la soci茅t茅, a re莽u une attribution de 60 000 unit茅s d'actions restreintes fond茅es sur le temps (RSU) le 16/08/2025. Les RSU ont 茅t茅 octroy茅es 脿 un prix d茅clar茅 de 0 $ et repr茅sentent des droits conditionnels 脿 une action ordinaire chacune. Apr猫s l'attribution, la personne d茅clarante d茅tenait b茅n茅ficiairement 95 210 actions. Les RSU acqui猫rent en trois versements annuels 茅gaux 脿 compter du premier anniversaire de la date d'attribution. Le formulaire Form 4 est dat茅 du 19/08/2025 et porte la signature de Justin Hunter au nom de Benjamin R. Wheeler.
Interne Gew盲hrung und daraus resultierender Anteil bei Myriad Genetics: Benjamin R. Wheeler, als Chief Financial Officer des Unternehmens genannt, erhielt am 16.08.2025 eine Zuteilung von 60.000 zeitabh盲ngigen Restricted Stock Units (RSUs). Die RSUs wurden zu einem angegebenen Preis von $0 gew盲hrt und stellen jeweils bedingte Rechte auf eine Stammaktie dar. Nach der Gew盲hrung besa脽 die meldende Person wirtschaftlich 95.210 Aktien. Die RSUs fallen in drei gleichen j盲hrlichen Raten ab dem ersten Jahrestag des Gew盲hrungsdatums an. Die Form 4 ist datiert auf 19.08.2025 und tr盲gt die Unterschrift von Justin Hunter im Namen von Benjamin R. Wheeler.
FAQ
What did Benjamin R. Wheeler report on Form 4 for MYGN?
How do the restricted stock units (RSUs) vest for the MYGN grant?
What price was reported for the RSU grant on the Form 4?
What is Benjamin R. Wheeler's role at Myriad Genetics as listed on the form?
When was the Form 4 filed and who signed it?
